Boston Scientific’s Penumbra deal open for views in EU
MLex Summary: Parties interested in plans by Boston Scientific to acquire rival US biomedical company Penumbra can now file comments to the European Commission. The EU merger regular has set a provsisional Dec....To view the full article, register now.
Already a subscriber? Click here to view full article